Subgen AI

4,53 SEK

-22,52 %

Mindre end 1K følgere

SUBGEN

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Oversigt

Finansielt overblik og estimater

Ejerskab

-22,52 %

-40,46 %

-25,82 %

-67,68 %

-62,31 %

-70,38 %

-99,31 %

-99,83 %

-99,64 %

Subgen AI develops both infrastructure and proprietary agent-centric AI-as-a-Service software, branded Serenity Star. The company's solutions are designed to scale and accelerate the implementation of AI in organizations. Subgen AI delivers services to clients in sectors such as healthcare, energy, legal and human resources. Subgen AI operates in Europe, Latin America and the United States.

Markedsværdi

2,35 mia. SEK

Aktieomsætning

1,02 mio. SEK

Omsætning

-

EBIT %

-

P/E

-

Udbytteafkast, %

-

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender

17.12

2025

Ekstraordinær generalforsamling '26

31.3

2026

Årsrapport '25

7.5

2026

Delårsrapport Q1'26

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Selskabsmeddelelse28.11.2025, 12.50

Notice of extraordinary general meeting in Subgen AI AB

Pressemeddelelse28.11.2025, 07.30

Subgen AI to present at Redeye Technology Day 2025

Selskabsmeddelelse28.11.2025, 07.00

Subgen AI AB: Certain sellers of Subgen AI Limited, including newly appointed members of the board and management, have entered into lock-up agreements

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Pressemeddelelse27.11.2025, 07.00

Subgen AI announces strategic integration partnership with DISID to accelerate enterprise adoption

Selskabsmeddelelse21.11.2025, 07.45

Subgen AI AB: First day of trading under new ticker SUBGEN on Nasdaq First North Growth Market

Selskabsmeddelelse20.11.2025, 14.40

Record date for reverse share split in Subgen AI AB and recalculation of warrants of series TO 5 and TO 6

Selskabsmeddelelse20.11.2025, 10.05

Subgen AI AB updates its website and announces that the first day of trading under the new ticker will take place on 21 November 2025

Selskabsmeddelelse6.11.2025, 21.46

Magnasense completes the reverse takeover of Subgen AI

Selskabsmeddelelse6.11.2025, 16.54

Magnasense completes the sale of its subsidiaries

Selskabsmeddelelse5.11.2025, 11.08

Bulletin from the extraordinary general meeting in Magnasense AB on 5 November 2025

Selskabsmeddelelse29.10.2025, 07.55

Magnasense receives conditional approval for continued listing on Nasdaq First North Growth Market and publishes company description in connection with the reverse takeover of Subgen AI

Selskabsmeddelelse21.10.2025, 19.05

Subgen AI Foundation receives exemption from the Swedish Securities Council regarding mandatory bid in connection with Magnasense’s conditional reverse takeover of Subgen AI Limited

Selskabsmeddelelse3.10.2025, 10.26

Notice of extraordinary general meeting in Magnasense AB (publ)

Selskabsmeddelelse29.9.2025, 20.36

Magnasense enters into a conditional settlement agreement with Atlas Special Opportunities, terminating all prior agreements and settling all existing claims through an intended directed issue

Selskabsmeddelelse20.9.2025, 13.06

Magnasense progresses planned reverse takeover by entering into a conditional share purchase agreement regarding the sale of its subsidiaries - Marco Witteveen to step down as CEO

Selskabsmeddelelse29.8.2025, 06.55

Magnasense Interim Report January - June 2025

Selskabsmeddelelse22.7.2025, 21.46

Magnasense enters into a conditional agreement regarding a reverse takeover of Subgen AI Limited

Selskabsmeddelelse16.7.2025, 19.14

Magnasense AB carries out directed issue of 784,095,000 shares to Atlas Special Opportunities, LLC following called upon conversions of approximately SEK 1.57 million

Selskabsmeddelelse14.7.2025, 20.36

The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended

Selskabsmeddelelse14.7.2025, 16.22

Magnasense AB files appeal against decision by Swedish Financial Supervisory Authority

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.